NeurologyLive® Friday 5 — June 30, 2023

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: International Journal of MS Care: May/June 2023 Highlights

Review the latest peer-reviewed articles dedicated to the multidisciplinary management of multiple sclerosis published in the International Journal of MS Care.

2: Peer Exchange: Comparison of Biosimilar Products and Reference Products

In episode 2 of this Peer Exchange series "How Similar are Biosimilars? A look into the Future with Biosimilars in Multiple Sclerosis", clinical experts discuss differences and similarities between biosimilars and reference products.

3: NeuroVoices: Burel Goodin, PhD, on Improving Pain Medicine Care in Underserved Populations

In the latest edition of our in-depth Q&A series, the professor of anesthesiology at Washington University in St. Louis provided insight on his presentation at AHS 2023 discussing the need to engage underserved populations.

4: Air Pollution’s Impact on Cognitive Decline and the Neurotoxicity of Particulate Matter: Masashi Kitazawa, PhD

The associate professor of environmental and occupational Health at the University of California, Irvine, talked about the impact of concentrated particulate matter or air pollution on cognitive function in animal models. [WATCH TIME: 5 minutes]

5: Importance of Diversity and Inclusion in MS Care for the LGBTQ+ Patient Population: William L. Conte, MD, MS

The head of the MS Center at Methodist Hospitals and assistant professor of neurology at Indiana University talked about the significance of diversity and the health disparities faced by patients with multiple sclerosis in the LGBTQ+ community. [WATCH TIME: 3 minutes]